SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VaxGen Inc.-The 1st AIDS Vaccine in Phase 3 HumanTrials

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: William Stanton who wrote (11)5/29/1999 1:16:00 AM
From: glen  Read Replies (1) of 250
 
Sounds like you've been to their roadshows. I have seen both movies, coincidentally only, and have met twice with Francis and Nowinski. Did you have an opportunity to take part in either (or both) of the private placements?

Let's not forget that in addition to it's development as a vaccine, AIDVAX is also being used as a booster to France's Pasteur Institute's two-part vaccine. This is VaxGens closest competitor, although nowhere nears as advanced in development as VaxGen. But, isn't it nice to know that part of the competitions model uses AIDVAX as the second shot booster? To sum this all up, we both seem to feel that VaxGen has the potential to become a HOT,HOT, HOT investment!!!

BTW, nice to see a new face on the thread. Hopefully, things here will pick up after the IPO.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext